EP2700651
Samsetningar eingildar fyrir CD28-bindingu og aðferðir til notkunar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.7.2009EP published:
10.4.2019EP application number:
13185422.6
EP translation filed:
11.6.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
16.7.2029Expiry date:
16.7.2022
Title:
Compositions monovalent for CD28 binding and methods of use
Timeline
Today
17.7.2009EP application
10.4.2019EP Publication
11.6.2019Translation submitted
15.7.2019Registration published
16.7.2022Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Name:
Domantis LimitedAddress:
980 Great West Road, Brentford, Middlesex TW8 9GS, GB
Inventor
Name:
McKinnon, MurrayAddress:
Doylestown, PA, US
Name:
Nadler, Steven G.Address:
Princeton, NJ, US
Name:
Suchard, Suzanne J.Address:
Portland, OR, US
Name:
Classon, BrendanAddress:
Princeton, NJ, US
Name:
Holmes, SteveAddress:
Cambridge Cambridgeshire CB4 0WG, GB
Name:
Ignatovich, OlgaAddress:
Cambridge Cambridgeshire CB4 0WG, GB
Name:
Plummer, ChristopherAddress:
Cambridge Cambridgeshire CB4 0WG, GB
Name:
Grant, SteveAddress:
Cambridge Cambridgeshire CB4 0WG, GB
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
82078 PDate:
18.7.2008Country:
US
Number:
162121 PDate:
20.3.2009Country:
US
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 5.6.2019
Expires: 16.7.2020
Payer: Árnason Faktor
Number: 12
Paid: 12.6.2020
Expires: 16.7.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.6.2021
Expires: 16.7.2022
Payer: Árnason Faktor ehf.